Summary

Definition and Scope:
The market for Classical Swine Fever (CSF) vaccines is driven by the need to control and prevent outbreaks of this highly contagious viral disease affecting swine populations worldwide. CSF, also known as hog cholera, causes significant economic losses due to high mortality rates, trade restrictions, and production disruptions. The vaccines are categorized into live attenuated, inactivated, and subunit types, with live attenuated vaccines being the most widely used due to their efficacy and cost-effectiveness. Demand is particularly strong in regions with large swine industries, such as Asia (especially China, Vietnam, and South Korea), Europe, and Latin America, where governments and producers prioritize biosecurity measures. The market is further influenced by regulatory policies, vaccination mandates, and the emergence of new strains requiring updated vaccine formulations. Increasing pork consumption and intensification of pig farming also contribute to market growth, with key players focusing on R&D for safer, more effective vaccines. However, challenges include vaccine storage requirements, the risk of reversion to virulence in live vaccines, and trade barriers in CSF-free regions that restrict vaccine use.
This report offers a comprehensive analysis of the global Classical Swine Fever Vaccines market, examining all key dimensions. It provides both a macro-level overview and micro-level market details, including market size, trends, competitive landscape, niche segments, growth drivers, and key challenges.

The global Classical Swine Fever Vaccines market size was estimated at USD 197.25 million in 2025 and is projected to grow at a compound annual growth rate (CAGR) of 5.50% during the forecast period.

Report Framework and Key Highlights:
Market Dynamics: Identification of major market drivers, restraints, opportunities, and challenges.
Trend Analysis: Examination of ongoing and emerging trends impacting the market.
Competitive Landscape: Detailed profiles and market positioning of major players, including market share, operational status, product offerings, and strategic developments.
Strategic Analysis Tools: SWOT Analysis, Porter’s Five Forces Analysis, PEST Analysis, Value Chain Analysis
Market Segmentation: By type, application, region, and end-user industry.
Forecasting and Growth Projections: In-depth revenue forecasts and CAGR analysis through 2033.
This report equips readers with critical insights to navigate competitive dynamics and develop effective strategies. Whether assessing a new market entry or refining existing strategies, the report serves as a valuable tool for:
Industry players
Investors
Researchers
Consultants
Business strategists
And all stakeholders with an interest or investment in the Classical Swine Fever Vaccines market.

Global Classical Swine Fever Vaccines Market: Market Segmentation Analysis
The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.
Key Companies Profiled
WINSUN
Merial
CAHIC
Chopper Biology
MSD Animal Health (Merck)
ChengDu Tecbond
Ceva
Harbin Veterinary Research Institute
Qilu Animal Health Products Factory
Ringpu Biology
DHN
CAVAC
Komipharm
Agrovet
Bioveta
Jinyu Bio-Technology
Institutul Pasteur
MVP
Tecon

Market Segmentation by Type
Tissue Culture Origin
Cell Line Origin

Market Segmentation by Application
Disease prevention and control
Medical research

Geographic Segmentation
North America: United States, Canada, Mexico
Europe: Germany, France, Italy, U.K., Spain, Sweden, Denmark, Netherlands, Switzerland, Belgium, Russia.
Asia-Pacific: China, Japan, South Korea, India, Australia, Indonesia, Malaysia, Philippines, Singapore, Thailand
South America: Brazil, Argentina, Colombia.
Middle East and Africa (MEA): Saudi Arabia, United Arab Emirates, Egypt, Nigeria, South Africa, Rest of MEA

Report Framework and Chapter Summary
Chapter 1: Report Scope and Market Definition
This chapter outlines the statistical boundaries and scope of the report. It defines the segmentation standards used throughout the study, including criteria for dividing the market by region, product type, application, and other relevant dimensions. It establishes the foundational definitions and classifications that guide the rest of the analysis.
Chapter 2: Executive Summary
This chapter presents a concise summary of the market’s current status and future outlook across different segments—by geography, product type, and application. It includes key metrics such as market size, growth trends, and development potential for each segment. The chapter offers a high-level overview of the Classical Swine Fever Vaccines Market, highlighting its evolution over the short, medium, and long term.
Chapter 3: Competitive Landscape
This chapter provides a detailed assessment of the market's competitive environment. It covers market share, production capacity, output, pricing trends, and strategic developments such as mergers, acquisitions, and expansion plans of leading players. This analysis offers a comprehensive view of the positioning and performance of top competitors.
Chapter 4: Industry Chain and Value Chain Analysis
This chapter explores the full industry chain, from upstream raw material suppliers to downstream application sectors. It includes a value chain analysis that highlights the interconnections and dependencies across various parts of the ecosystem.
Chapter 5: Market Dynamics and Policy Environment
This chapter explores the latest developments in the market, identifying key growth drivers, restraints, challenges, and risks faced by industry participants. It also includes an analysis of the policy and regulatory landscape affecting the market, providing insight into how external factors may shape future performance.
Chapter 6: Market Segmentation by Product Type
This chapter examines the market based on product type, analyzing the size, growth trends, and potential of each segment. It helps stakeholders identify underexplored or high-potential product categories—often referred to as “blue ocean” opportunities.
Chapter 7: Market Segmentation by Application
This chapter analyzes the market based on application fields, providing insights into the scale and future development of each application segment. It supports readers in identifying high-growth areas across downstream markets.
Chapters 8: Regional Market Analysis by Consumption
These chapters offer in-depth, quantitative evaluations of market size and growth potential across major regions and countries. Each chapter assesses regional consumption patterns, market dynamics, development prospects, and available capacity. The analysis helps readers understand geographical differences and opportunities in global markets.
Chapter 9: Regional Market Analysis by Production
These chapters shares the main producing countries of Classical Swine Fever Vaccines, their output value, profit level, regional supply, production capacity layout, etc. from the supply side.
Chapter 10: Company Profiles
This chapter presents comprehensive profiles of leading companies operating in the market. For each company, it details sales revenue, volume, pricing, gross profit margin, market share, product offerings, and recent strategic developments. This section offers valuable insight into corporate performance and strategy.
Chapter 12: Key Findings and Conclusions
The final chapter summarizes the main takeaways from the report, presenting the core conclusions, strategic recommendations, and implications for stakeholders. It encapsulates the insights drawn from all previous chapters.

ページTOPに戻る

Table of Contents

Table of Contents
1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Classical Swine Fever Vaccines
1.2 Key Market Segments
1.2.1 Classical Swine Fever Vaccines Segment by Type
1.2.2 Classical Swine Fever Vaccines Segment by Application
1.3 Methodology & Sources of Information
2
3 Global Classical Swine Fever Vaccines Market Overview
3.1 Global Classical Swine Fever Vaccines Market Overview
3.1.1 Global Classical Swine Fever Vaccines Market Size and Forecasts (2020-2035)
3.1.2 Global Classical Swine Fever Vaccines Market: Capacity and Utilization Outlook (2020–2035)
3.2 Market Segment Executive Summary
3.3 Global Market Size by Region
4 Classical Swine Fever Vaccines Market Competitive Landscape
4.1 Company Assessment Quadrant
4.2 Global Classical Swine Fever Vaccines Product Life Cycle
4.3 Global Classical Swine Fever Vaccines Sales by Manufacturers (2020-2025)
4.4 Global Classical Swine Fever Vaccines Revenue Market Share by Manufacturers (2020-2025)
4.5 Classical Swine Fever Vaccines Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
4.6 Global Classical Swine Fever Vaccines Average Price by Manufacturers (2020-2025)
4.7 Production Capacity and Capacity Utilization Rate of Major Classical Swine Fever Vaccines Manufacturers
4.8 Manufacturers’ Manufacturing Sites, Areas Served, and Product Types
4.9 Classical Swine Fever Vaccines Market Competitive Situation and Trends
4.9.1 Classical Swine Fever Vaccines Market Concentration Rate
4.9.2 Global 5 and 10 Largest Classical Swine Fever Vaccines Players Market Share by Revenue
4.9.3 Mergers & Acquisitions, Expansion
5 Classical Swine Fever Vaccines Industry Chain Analysis
5.1 Classical Swine Fever Vaccines Industry Chain Analysis
5.2 Market Overview of Key Raw Materials
5.3 Midstream Market Analysis
5.4 Downstream Customer Analysis
6 The Development and Dynamics of Classical Swine Fever Vaccines Market
6.1 Key Development Trends
6.2 Driving Factors
6.3 Market Challenges
6.4 Industry News
6.4.1 New Product Developments
6.4.2 Mergers & Acquisitions
6.4.3 Expansions
6.4.4 Collaboration/Supply Contracts
6.5 PEST Analysis
6.5.1 Political Environment Analysis
6.5.2 Economic Environment Analysis
6.5.3 Social Environment Analysis
6.5.4 Technological Environment Analysis
6.6 Global Classical Swine Fever Vaccines Market Porter's Five Forces Analysis
6.6.1 Global Trade Frictions
6.6.2 U.S. Tariff Policy
6.6.3 Global Trade Frictions and Their Impacts on Classical Swine Fever Vaccines Market
7 Classical Swine Fever Vaccines Market Segmentation by Type
7.1 Evaluation Matrix of Segment Market Development Potential (Type)
7.2 Global Classical Swine Fever Vaccines Sales Market Share by Type (2020-2025)
7.3 Global Classical Swine Fever Vaccines Market Size by Type (2020-2025)
7.4 Global Classical Swine Fever Vaccines Price by Type (2020-2025)
8 Classical Swine Fever Vaccines Market Segmentation by Application
8.1 Evaluation Matrix of Segment Market Development Potential (Application)
8.2 Global Classical Swine Fever Vaccines Market Sales by Application (2020-2025)
8.3 Global Classical Swine Fever Vaccines Market Size (M USD) by Application (2020-2025)
8.4 Global Classical Swine Fever Vaccines Sales Growth Rate by Application (2020-2025)
9 Classical Swine Fever Vaccines Market Segmentation by Region
9.1 Global Classical Swine Fever Vaccines Sales by Region
9.1.1 Global Classical Swine Fever Vaccines Sales by Region
9.1.2 Global Classical Swine Fever Vaccines Sales Market Share by Region
9.2 Global Classical Swine Fever Vaccines Market Size by Region
9.2.1 Global Classical Swine Fever Vaccines Market Size by Region
9.2.2 Global Classical Swine Fever Vaccines Market Size by Region
9.3 North America
9.3.1 North America Classical Swine Fever Vaccines Sales by Country
9.3.2 North America Classical Swine Fever Vaccines Market Size by Country
9.3.3 U.S. Market Overview
9.3.4 Canada Market Overview
9.3.5 Mexico Market Overview
9.4 Europe
9.4.1 Europe Classical Swine Fever Vaccines Sales by Country
9.4.2 Europe Classical Swine Fever Vaccines Market Size by Country
9.4.3 Germany Market Overview
9.4.4 France Market Overview
9.4.5 U.K. Market Overview
9.4.6 Italy Market Overview
9.4.7 Spain Market Overview
9.5 Asia Pacific
9.5.1 Asia Pacific Classical Swine Fever Vaccines Sales by Region
9.5.2 Asia Pacific Classical Swine Fever Vaccines Market Size by Region
9.5.3 China Market Overview
9.5.4 Japan Market Overview
9.5.5 South Korea Market Overview
9.5.6 India Market Overview
9.5.7 Southeast Asia Market Overview
9.6 South America
9.6.1 South America Classical Swine Fever Vaccines Sales by Country
9.6.2 South America Classical Swine Fever Vaccines Market Size by Country
9.6.3 Brazil Market Overview
9.6.4 Argentina Market Overview
9.6.5 Columbia Market Overview
9.7 Middle East and Africa
9.7.1 Middle East and Africa Classical Swine Fever Vaccines Sales by Region
9.7.2 Middle East and Africa Classical Swine Fever Vaccines Market Size by Region
9.7.3 Saudi Arabia Market Overview
9.7.4 UAE Market Overview
9.7.5 Egypt Market Overview
9.7.6 Nigeria Market Overview
9.7.7 South Africa Market Overview
10 Classical Swine Fever Vaccines Market Production by Region
10.1 Global Production of Classical Swine Fever Vaccines by Region(2020-2025)
10.2 Global Classical Swine Fever Vaccines Revenue Market Share by Region (2020-2025)
10.3 Global Classical Swine Fever Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
10.4 North America Classical Swine Fever Vaccines Production
10.4.1 North America Classical Swine Fever Vaccines Production Growth Rate (2020-2025)
10.4.2 North America Classical Swine Fever Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
10.5 Europe Classical Swine Fever Vaccines Production
10.5.1 Europe Classical Swine Fever Vaccines Production Growth Rate (2020-2025)
10.5.2 Europe Classical Swine Fever Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
10.6 Japan Classical Swine Fever Vaccines Production (2020-2025)
10.6.1 Japan Classical Swine Fever Vaccines Production Growth Rate (2020-2025)
10.6.2 Japan Classical Swine Fever Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
10.7 China Classical Swine Fever Vaccines Production (2020-2025)
10.7.1 China Classical Swine Fever Vaccines Production Growth Rate (2020-2025)
10.7.2 China Classical Swine Fever Vaccines Production, Revenue, Price and Gross Margin (2020-2025)
11 Key Companies Profile
11.1 WINSUN
11.1.1 WINSUN Basic Information
11.1.2 WINSUN Classical Swine Fever Vaccines Product Overview
11.1.3 WINSUN Classical Swine Fever Vaccines Product Market Performance
11.1.4 WINSUN Business Overview
11.1.5 WINSUN SWOT Analysis
11.1.6 WINSUN Recent Developments
11.2 Merial
11.2.1 Merial Basic Information
11.2.2 Merial Classical Swine Fever Vaccines Product Overview
11.2.3 Merial Classical Swine Fever Vaccines Product Market Performance
11.2.4 Merial Business Overview
11.2.5 Merial SWOT Analysis
11.2.6 Merial Recent Developments
11.3 CAHIC
11.3.1 CAHIC Basic Information
11.3.2 CAHIC Classical Swine Fever Vaccines Product Overview
11.3.3 CAHIC Classical Swine Fever Vaccines Product Market Performance
11.3.4 CAHIC Business Overview
11.3.5 CAHIC SWOT Analysis
11.3.6 CAHIC Recent Developments
11.4 Chopper Biology
11.4.1 Chopper Biology Basic Information
11.4.2 Chopper Biology Classical Swine Fever Vaccines Product Overview
11.4.3 Chopper Biology Classical Swine Fever Vaccines Product Market Performance
11.4.4 Chopper Biology Business Overview
11.4.5 Chopper Biology Recent Developments
11.5 MSD Animal Health (Merck)
11.5.1 MSD Animal Health (Merck) Basic Information
11.5.2 MSD Animal Health (Merck) Classical Swine Fever Vaccines Product Overview
11.5.3 MSD Animal Health (Merck) Classical Swine Fever Vaccines Product Market Performance
11.5.4 MSD Animal Health (Merck) Business Overview
11.5.5 MSD Animal Health (Merck) Recent Developments
11.6 ChengDu Tecbond
11.6.1 ChengDu Tecbond Basic Information
11.6.2 ChengDu Tecbond Classical Swine Fever Vaccines Product Overview
11.6.3 ChengDu Tecbond Classical Swine Fever Vaccines Product Market Performance
11.6.4 ChengDu Tecbond Business Overview
11.6.5 ChengDu Tecbond Recent Developments
11.7 Ceva
11.7.1 Ceva Basic Information
11.7.2 Ceva Classical Swine Fever Vaccines Product Overview
11.7.3 Ceva Classical Swine Fever Vaccines Product Market Performance
11.7.4 Ceva Business Overview
11.7.5 Ceva Recent Developments
11.8 Harbin Veterinary Research Institute
11.8.1 Harbin Veterinary Research Institute Basic Information
11.8.2 Harbin Veterinary Research Institute Classical Swine Fever Vaccines Product Overview
11.8.3 Harbin Veterinary Research Institute Classical Swine Fever Vaccines Product Market Performance
11.8.4 Harbin Veterinary Research Institute Business Overview
11.8.5 Harbin Veterinary Research Institute Recent Developments
11.9 Qilu Animal Health Products Factory
11.9.1 Qilu Animal Health Products Factory Basic Information
11.9.2 Qilu Animal Health Products Factory Classical Swine Fever Vaccines Product Overview
11.9.3 Qilu Animal Health Products Factory Classical Swine Fever Vaccines Product Market Performance
11.9.4 Qilu Animal Health Products Factory Business Overview
11.9.5 Qilu Animal Health Products Factory Recent Developments
11.10 Ringpu Biology
11.10.1 Ringpu Biology Basic Information
11.10.2 Ringpu Biology Classical Swine Fever Vaccines Product Overview
11.10.3 Ringpu Biology Classical Swine Fever Vaccines Product Market Performance
11.10.4 Ringpu Biology Business Overview
11.10.5 Ringpu Biology Recent Developments
11.11 DHN
11.11.1 DHN Basic Information
11.11.2 DHN Classical Swine Fever Vaccines Product Overview
11.11.3 DHN Classical Swine Fever Vaccines Product Market Performance
11.11.4 DHN Business Overview
11.11.5 DHN Recent Developments
11.12 CAVAC
11.12.1 CAVAC Basic Information
11.12.2 CAVAC Classical Swine Fever Vaccines Product Overview
11.12.3 CAVAC Classical Swine Fever Vaccines Product Market Performance
11.12.4 CAVAC Business Overview
11.12.5 CAVAC Recent Developments
11.13 Komipharm
11.13.1 Komipharm Basic Information
11.13.2 Komipharm Classical Swine Fever Vaccines Product Overview
11.13.3 Komipharm Classical Swine Fever Vaccines Product Market Performance
11.13.4 Komipharm Business Overview
11.13.5 Komipharm Recent Developments
11.14 Agrovet
11.14.1 Agrovet Basic Information
11.14.2 Agrovet Classical Swine Fever Vaccines Product Overview
11.14.3 Agrovet Classical Swine Fever Vaccines Product Market Performance
11.14.4 Agrovet Business Overview
11.14.5 Agrovet Recent Developments
11.15 Bioveta
11.15.1 Bioveta Basic Information
11.15.2 Bioveta Classical Swine Fever Vaccines Product Overview
11.15.3 Bioveta Classical Swine Fever Vaccines Product Market Performance
11.15.4 Bioveta Business Overview
11.15.5 Bioveta Recent Developments
11.16 Jinyu Bio-Technology
11.16.1 Jinyu Bio-Technology Basic Information
11.16.2 Jinyu Bio-Technology Classical Swine Fever Vaccines Product Overview
11.16.3 Jinyu Bio-Technology Classical Swine Fever Vaccines Product Market Performance
11.16.4 Jinyu Bio-Technology Business Overview
11.16.5 Jinyu Bio-Technology Recent Developments
11.17 Institutul Pasteur
11.17.1 Institutul Pasteur Basic Information
11.17.2 Institutul Pasteur Classical Swine Fever Vaccines Product Overview
11.17.3 Institutul Pasteur Classical Swine Fever Vaccines Product Market Performance
11.17.4 Institutul Pasteur Business Overview
11.17.5 Institutul Pasteur Recent Developments
11.18 MVP
11.18.1 MVP Basic Information
11.18.2 MVP Classical Swine Fever Vaccines Product Overview
11.18.3 MVP Classical Swine Fever Vaccines Product Market Performance
11.18.4 MVP Business Overview
11.18.5 MVP Recent Developments
11.19 Tecon
11.19.1 Tecon Basic Information
11.19.2 Tecon Classical Swine Fever Vaccines Product Overview
11.19.3 Tecon Classical Swine Fever Vaccines Product Market Performance
11.19.4 Tecon Business Overview
11.19.5 Tecon Recent Developments
12 Classical Swine Fever Vaccines Market Forecast by Region
12.1 Global Classical Swine Fever Vaccines Market Size Forecast
12.2 Global Classical Swine Fever Vaccines Market Forecast by Region
12.2.1 North America Market Size Forecast by Country
12.2.2 Europe Classical Swine Fever Vaccines Market Size Forecast by Country
12.2.3 Asia Pacific Classical Swine Fever Vaccines Market Size Forecast by Region
12.2.4 South America Classical Swine Fever Vaccines Market Size Forecast by Country
12.2.5 Middle East and Africa Classical Swine Fever Vaccines Market Size Forecast by Country
13 Forecast Market by Type and by Application (2026-2035)
13.1 Global Classical Swine Fever Vaccines Market Forecast by Type (2026-2035)
13.1.1 Global Forecasted Sales of Classical Swine Fever Vaccines by Type (2026-2035)
13.1.2 Global Classical Swine Fever Vaccines Market Size Forecast by Type (2026-2035)
13.1.3 Global Forecasted Price of Classical Swine Fever Vaccines by Type (2026-2035)
13.2 Global Classical Swine Fever Vaccines Market Forecast by Application (2026-2035)
13.2.1 Global Classical Swine Fever Vaccines Sales (K MT) Forecast by Application
13.2.2 Global Classical Swine Fever Vaccines Market Size (M USD) Forecast by Application (2026-2035)
14 Conclusion and Key Findings

ページTOPに戻る

List of Tables/Graphs

List of Tables
Table 1. Introduction of the Type
Table 2. Introduction of the Application
Table 3. Global Classical Swine Fever Vaccines Market Size by Type (M USD)
Table 4. Global Classical Swine Fever Vaccines Market Size by Application
Table 5. Classical Swine Fever Vaccines Market Size Comparison by Region (M USD)
Table 6. Classical Swine Fever Vaccines Market Size by Country (M USD)
Table 7. Global Classical Swine Fever Vaccines Sales (K MT) by Manufacturers (2020-2025)
Table 8. Global Classical Swine Fever Vaccines Sales Market Share by Manufacturers (2020-2025)
Table 9. Global Classical Swine Fever Vaccines Revenue (M USD) by Manufacturers (2020-2025)
Table 10. Global Classical Swine Fever Vaccines Revenue Share by Manufacturers (2020-2025)
Table 11. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Classical Swine Fever Vaccines as of 2025)
Table 12. Global Market Classical Swine Fever Vaccines Average Price (USD/KG) of Key Manufacturers (2020-2025)
Table 13. Production Capacity and Capacity Utilization Rate of Major Classical Swine Fever Vaccines Manufacturers in 2024
Table 14. Manufacturers’ Manufacturing Sites, Areas Served
Table 15. Manufacturers’ Product Type
Table 16. Global Classical Swine Fever Vaccines Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 17. Mergers & Acquisitions, Expansion Plans
Table 18. Market Overview of Key Raw Materials
Table 19. Midstream Market Lists
Table 20. Downstream Customer Analysis
Table 21. Key Development Trends
Table 22. Driving Factors
Table 23. Classical Swine Fever Vaccines Market Challenges
Table 24. World Bank's Forecast Real GDP Growth Rate for 2024-2028
Table 25. Goldman Sachs' Forecast Real GDP Growth Rate for 2025-2026
Table 26. IMF's Forecast Real GDP Growth Rate For 2024-2026
Table 27. The Tariff Rates Imposed by the United States on Major Commodity Trading Countries
Table 28. Global Classical Swine Fever Vaccines Sales by Type (K MT)
Table 29. Global Classical Swine Fever Vaccines Market Size by Type (M USD)
Table 30. Global Classical Swine Fever Vaccines Sales (K MT) by Type (2020-2025)
Table 31. Global Classical Swine Fever Vaccines Sales Market Share by Type (2020-2025)
Table 32. Global Classical Swine Fever Vaccines Market Size (M USD) by Type (2020-2025)
Table 33. Global Classical Swine Fever Vaccines Market Share by Type (2020-2025)
Table 34. Global Classical Swine Fever Vaccines Price (USD/KG) by Type (2020-2025)
Table 35. Global Classical Swine Fever Vaccines Sales (K MT) by Application
Table 36. Global Classical Swine Fever Vaccines Market Size by Application
Table 37. Global Classical Swine Fever Vaccines Sales by Application (2020-2025) & (K MT)
Table 38. Global Classical Swine Fever Vaccines Sales Market Share by Application (2020-2025)
Table 39. Global Classical Swine Fever Vaccines Market Size by Application (2020-2025) & (M USD)
Table 40. Global Classical Swine Fever Vaccines Market Share by Application (2020-2025)
Table 41. Global Classical Swine Fever Vaccines Sales Growth Rate by Application (2020-2025)
Table 42. Global Classical Swine Fever Vaccines Sales by Region (2020-2025) & (K MT)
Table 43. Global Classical Swine Fever Vaccines Sales Market Share by Region (2020-2025)
Table 44. Global Classical Swine Fever Vaccines Market Size by Region (2020-2025) & (M USD)
Table 45. Global Classical Swine Fever Vaccines Market Size by Region (2020-2025)
Table 46. North America Classical Swine Fever Vaccines Sales by Country (2020-2025) & (K MT)
Table 47. North America Classical Swine Fever Vaccines Market Size by Country (2020-2025) & (M USD)
Table 48. Europe Classical Swine Fever Vaccines Sales by Country (2020-2025) & (K MT)
Table 49. Europe Classical Swine Fever Vaccines Market Size by Country (2020-2025) & (M USD)
Table 50. Asia Pacific Classical Swine Fever Vaccines Sales by Region (2020-2025) & (K MT)
Table 51. Asia Pacific Classical Swine Fever Vaccines Market Size by Region (2020-2025) & (M USD)
Table 52. South America Classical Swine Fever Vaccines Sales by Country (2020-2025) & (K MT)
Table 53. South America Classical Swine Fever Vaccines Market Size by Country (2020-2025) & (M USD)
Table 54. Middle East and Africa Classical Swine Fever Vaccines Sales by Region (2020-2025) & (K MT)
Table 55. Middle East and Africa Classical Swine Fever Vaccines Market Size by Region (2020-2025) & (M USD)
Table 56. Global Classical Swine Fever Vaccines Production (K MT) by Region(2020-2025)
Table 57. Global Classical Swine Fever Vaccines Revenue (US$ Million) by Region (2020-2025)
Table 58. Global Classical Swine Fever Vaccines Revenue Market Share by Region (2020-2025)
Table 59. Global Classical Swine Fever Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 60. North America Classical Swine Fever Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 61. Europe Classical Swine Fever Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 62. Japan Classical Swine Fever Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 63. China Classical Swine Fever Vaccines Production (K MT), Revenue (US$ Million), Price (USD/KG) and Gross Margin (2020-2025)
Table 64. WINSUN Basic Information
Table 65. WINSUN Classical Swine Fever Vaccines Product Overview
Table 66. WINSUN Classical Swine Fever Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 67. WINSUN Business Overview
Table 68. WINSUN SWOT Analysis
Table 69. WINSUN Recent Developments
Table 70. Merial Basic Information
Table 71. Merial Classical Swine Fever Vaccines Product Overview
Table 72. Merial Classical Swine Fever Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 73. Merial Business Overview
Table 74. Merial SWOT Analysis
Table 75. Merial Recent Developments
Table 76. CAHIC Basic Information
Table 77. CAHIC Classical Swine Fever Vaccines Product Overview
Table 78. CAHIC Classical Swine Fever Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 79. CAHIC Business Overview
Table 80. CAHIC SWOT Analysis
Table 81. CAHIC Recent Developments
Table 82. Chopper Biology Basic Information
Table 83. Chopper Biology Classical Swine Fever Vaccines Product Overview
Table 84. Chopper Biology Classical Swine Fever Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 85. Chopper Biology Business Overview
Table 86. Chopper Biology Recent Developments
Table 87. MSD Animal Health (Merck) Basic Information
Table 88. MSD Animal Health (Merck) Classical Swine Fever Vaccines Product Overview
Table 89. MSD Animal Health (Merck) Classical Swine Fever Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 90. MSD Animal Health (Merck) Business Overview
Table 91. MSD Animal Health (Merck) Recent Developments
Table 92. ChengDu Tecbond Basic Information
Table 93. ChengDu Tecbond Classical Swine Fever Vaccines Product Overview
Table 94. ChengDu Tecbond Classical Swine Fever Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 95. ChengDu Tecbond Business Overview
Table 96. ChengDu Tecbond Recent Developments
Table 97. Ceva Basic Information
Table 98. Ceva Classical Swine Fever Vaccines Product Overview
Table 99. Ceva Classical Swine Fever Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 100. Ceva Business Overview
Table 101. Ceva Recent Developments
Table 102. Harbin Veterinary Research Institute Basic Information
Table 103. Harbin Veterinary Research Institute Classical Swine Fever Vaccines Product Overview
Table 104. Harbin Veterinary Research Institute Classical Swine Fever Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 105. Harbin Veterinary Research Institute Business Overview
Table 106. Harbin Veterinary Research Institute Recent Developments
Table 107. Qilu Animal Health Products Factory Basic Information
Table 108. Qilu Animal Health Products Factory Classical Swine Fever Vaccines Product Overview
Table 109. Qilu Animal Health Products Factory Classical Swine Fever Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 110. Qilu Animal Health Products Factory Business Overview
Table 111. Qilu Animal Health Products Factory Recent Developments
Table 112. Ringpu Biology Basic Information
Table 113. Ringpu Biology Classical Swine Fever Vaccines Product Overview
Table 114. Ringpu Biology Classical Swine Fever Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 115. Ringpu Biology Business Overview
Table 116. Ringpu Biology Recent Developments
Table 117. DHN Basic Information
Table 118. DHN Classical Swine Fever Vaccines Product Overview
Table 119. DHN Classical Swine Fever Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 120. DHN Business Overview
Table 121. DHN Recent Developments
Table 122. CAVAC Basic Information
Table 123. CAVAC Classical Swine Fever Vaccines Product Overview
Table 124. CAVAC Classical Swine Fever Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 125. CAVAC Business Overview
Table 126. CAVAC Recent Developments
Table 127. Komipharm Basic Information
Table 128. Komipharm Classical Swine Fever Vaccines Product Overview
Table 129. Komipharm Classical Swine Fever Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 130. Komipharm Business Overview
Table 131. Komipharm Recent Developments
Table 132. Agrovet Basic Information
Table 133. Agrovet Classical Swine Fever Vaccines Product Overview
Table 134. Agrovet Classical Swine Fever Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 135. Agrovet Business Overview
Table 136. Agrovet Recent Developments
Table 137. Bioveta Basic Information
Table 138. Bioveta Classical Swine Fever Vaccines Product Overview
Table 139. Bioveta Classical Swine Fever Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 140. Bioveta Business Overview
Table 141. Bioveta Recent Developments
Table 142. Jinyu Bio-Technology Basic Information
Table 143. Jinyu Bio-Technology Classical Swine Fever Vaccines Product Overview
Table 144. Jinyu Bio-Technology Classical Swine Fever Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 145. Jinyu Bio-Technology Business Overview
Table 146. Jinyu Bio-Technology Recent Developments
Table 147. Institutul Pasteur Basic Information
Table 148. Institutul Pasteur Classical Swine Fever Vaccines Product Overview
Table 149. Institutul Pasteur Classical Swine Fever Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 150. Institutul Pasteur Business Overview
Table 151. Institutul Pasteur Recent Developments
Table 152. MVP Basic Information
Table 153. MVP Classical Swine Fever Vaccines Product Overview
Table 154. MVP Classical Swine Fever Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 155. MVP Business Overview
Table 156. MVP Recent Developments
Table 157. Tecon Basic Information
Table 158. Tecon Classical Swine Fever Vaccines Product Overview
Table 159. Tecon Classical Swine Fever Vaccines Sales (K MT), Revenue (M USD), Price (USD/KG) and Gross Margin (2020-2025)
Table 160. Tecon Business Overview
Table 161. Tecon Recent Developments
Table 162. Global Classical Swine Fever Vaccines Sales Forecast by Region (2026-2035) & (K MT)
Table 163. Global Classical Swine Fever Vaccines Market Size Forecast by Region (2026-2035) & (M USD)
Table 164. North America Classical Swine Fever Vaccines Sales Forecast by Country (2026-2035) & (K MT)
Table 165. North America Classical Swine Fever Vaccines Market Size Forecast by Country (2026-2035) & (M USD)
Table 166. Europe Classical Swine Fever Vaccines Sales Forecast by Country (2026-2035) & (K MT)
Table 167. Europe Classical Swine Fever Vaccines Market Size Forecast by Country (2026-2035) & (M USD)
Table 168. Asia Pacific Classical Swine Fever Vaccines Sales Forecast by Region (2026-2035) & (K MT)
Table 169. Asia Pacific Classical Swine Fever Vaccines Market Size Forecast by Region (2026-2035) & (M USD)
Table 170. South America Classical Swine Fever Vaccines Sales Forecast by Country (2026-2035) & (K MT)
Table 171. South America Classical Swine Fever Vaccines Market Size Forecast by Country (2026-2035) & (M USD)
Table 172. Middle East and Africa Classical Swine Fever Vaccines Sales Forecast by Country (2026-2035) & (K MT)
Table 173. Middle East and Africa Classical Swine Fever Vaccines Market Size Forecast by Country (2026-2035) & (M USD)
Table 174. Global Classical Swine Fever Vaccines Sales Forecast by Type (2026-2035) & (K MT)
Table 175. Global Classical Swine Fever Vaccines Market Size Forecast by Type (2026-2035) & (M USD)
Table 176. Global Classical Swine Fever Vaccines Price Forecast by Type (2026-2035) & (USD/KG)
Table 177. Global Classical Swine Fever Vaccines Sales (K MT) Forecast by Application (2026-2035)
Table 178. Global Classical Swine Fever Vaccines Market Size Forecast by Application (2026-2035) & (M USD)
List of Figures
Figure 1. Product Picture of Classical Swine Fever Vaccines
Figure 2. Global Classical Swine Fever Vaccines Market Size (M USD) (2020-2035)
Figure 3. Global Classical Swine Fever Vaccines Sales (K MT) & (2020-2035)
Figure 4. Global Classical Swine Fever Vaccines Market: Capacity and Utilization Outlook (2020-2035)
Figure 5. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 6. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 7. Evaluation Matrix of Regional Market Development Potential
Figure 8. Company Assessment Quadrant
Figure 9. Global Classical Swine Fever Vaccines Product Life Cycle
Figure 10. Classical Swine Fever Vaccines Sales Share by Manufacturers in 2025
Figure 11. Global Classical Swine Fever Vaccines Revenue Share by Manufacturers in 2025
Figure 12. Classical Swine Fever Vaccines Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2025
Figure 13. Global Market Classical Swine Fever Vaccines Average Price (USD/KG) of Key Manufacturers in 2025
Figure 14. The Global 5 and 10 Largest Players: Market Share by Classical Swine Fever Vaccines Revenue in 2025
Figure 15. Industry Chain Map of Classical Swine Fever Vaccines
Figure 16. Classical Swine Fever Vaccines Market Share of Key Raw Materials (2025)
Figure 17. Key Driving Factors - Impact Assessment
Figure 18. Market Challenges - Severity vs. Frequency Matrix
Figure 19. Key Industry News Timeline
Figure 20. Global Classical Swine Fever Vaccines Market PEST Analysis
Figure 21. Global Classical Swine Fever Vaccines Market Porter's Five Forces Analysis
Figure 22. Global Merchandise Trade as a Percentage Of GDP
Figure 23. US - lmports of Goods by Country
Figure 24. China Exports by Country
Figure 25. Evaluation Matrix of Segment Market Development Potential (Type)
Figure 26. Global Classical Swine Fever Vaccines Market Share by Type
Figure 27. Sales Market Share of Classical Swine Fever Vaccines by Type (2020-2025)
Figure 28. Sales Market Share of Classical Swine Fever Vaccines by Type in 2025
Figure 29. Market Share of Classical Swine Fever Vaccines by Type (2020-2025)
Figure 30. Market Share of Classical Swine Fever Vaccines by Type in 2025
Figure 31. Evaluation Matrix of Segment Market Development Potential (Application)
Figure 32. Global Classical Swine Fever Vaccines Market Share by Application
Figure 33. Global Classical Swine Fever Vaccines Sales Market Share by Application (2020-2025)
Figure 34. Global Classical Swine Fever Vaccines Sales Market Share by Application in 2025
Figure 35. Global Classical Swine Fever Vaccines Market Share by Application (2020-2025)
Figure 36. Global Classical Swine Fever Vaccines Market Share by Application in 2025
Figure 37. Global Classical Swine Fever Vaccines Sales Growth Rate by Application (2020-2025)
Figure 38. Global Classical Swine Fever Vaccines Sales Market Share by Region (2020-2025)
Figure 39. Global Classical Swine Fever Vaccines Market Size by Region (2020-2025)
Figure 40. North America Classical Swine Fever Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 41. North America Classical Swine Fever Vaccines Sales Market Share by Country in 2024
Figure 42. North America Classical Swine Fever Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 43. North America Classical Swine Fever Vaccines Market Size by Country in 2024
Figure 44. U.S. Classical Swine Fever Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 45. U.S. Classical Swine Fever Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 46. Canada Classical Swine Fever Vaccines Sales (K MT) and Growth Rate (2020-2025)
Figure 47. Canada Classical Swine Fever Vaccines Market Size (M USD) and Growth Rate (2020-2025)
Figure 48. Mexico Classical Swine Fever Vaccines Sales (K MT) and Growth Rate (2020-2025)
Figure 49. Mexico Classical Swine Fever Vaccines Market Size (M USD) and Growth Rate (2020-2025)
Figure 50. Europe Classical Swine Fever Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 51. Europe Classical Swine Fever Vaccines Sales Market Share by Country in 2024
Figure 52. Europe Classical Swine Fever Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 53. Europe Classical Swine Fever Vaccines Market Size by Country in 2024
Figure 54. Germany Classical Swine Fever Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 55. Germany Classical Swine Fever Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 56. France Classical Swine Fever Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 57. France Classical Swine Fever Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 58. U.K. Classical Swine Fever Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 59. U.K. Classical Swine Fever Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 60. Italy Classical Swine Fever Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 61. Italy Classical Swine Fever Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 62. Spain Classical Swine Fever Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 63. Spain Classical Swine Fever Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 64. Asia Pacific Classical Swine Fever Vaccines Sales and Growth Rate (K MT)
Figure 65. Asia Pacific Classical Swine Fever Vaccines Sales Market Share by Region in 2024
Figure 66. Asia Pacific Classical Swine Fever Vaccines Market Size by Region in 2024
Figure 67. China Classical Swine Fever Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 68. China Classical Swine Fever Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 69. Japan Classical Swine Fever Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 70. Japan Classical Swine Fever Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 71. South Korea Classical Swine Fever Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 72. South Korea Classical Swine Fever Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 73. India Classical Swine Fever Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 74. India Classical Swine Fever Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 75. Southeast Asia Classical Swine Fever Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 76. Southeast Asia Classical Swine Fever Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 77. South America Classical Swine Fever Vaccines Sales and Growth Rate (K MT)
Figure 78. South America Classical Swine Fever Vaccines Sales Market Share by Country in 2024
Figure 79. South America Classical Swine Fever Vaccines Market Size and Growth Rate (M USD)
Figure 80. South America Classical Swine Fever Vaccines Market Size by Country in 2024
Figure 81. Brazil Classical Swine Fever Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 82. Brazil Classical Swine Fever Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 83. Argentina Classical Swine Fever Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 84. Argentina Classical Swine Fever Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 85. Columbia Classical Swine Fever Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 86. Columbia Classical Swine Fever Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 87. Middle East and Africa Classical Swine Fever Vaccines Sales and Growth Rate (K MT)
Figure 88. Middle East and Africa Classical Swine Fever Vaccines Sales Market Share by Region in 2024
Figure 89. Middle East and Africa Classical Swine Fever Vaccines Market Size and Growth Rate (M USD)
Figure 90. Middle East and Africa Classical Swine Fever Vaccines Market Size by Region in 2024
Figure 91. Saudi Arabia Classical Swine Fever Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 92. Saudi Arabia Classical Swine Fever Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 93. UAE Classical Swine Fever Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 94. UAE Classical Swine Fever Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 95. Egypt Classical Swine Fever Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 96. Egypt Classical Swine Fever Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 97. Nigeria Classical Swine Fever Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 98. Nigeria Classical Swine Fever Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 99. South Africa Classical Swine Fever Vaccines Sales and Growth Rate (2020-2025) & (K MT)
Figure 100. South Africa Classical Swine Fever Vaccines Market Size and Growth Rate (2020-2025) & (M USD)
Figure 101. Global Classical Swine Fever Vaccines Production Market Share by Region (2020-2025)
Figure 102. North America Classical Swine Fever Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 103. Europe Classical Swine Fever Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 104. Japan Classical Swine Fever Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 105. China Classical Swine Fever Vaccines Production (K MT) Growth Rate (2020-2025)
Figure 106. Global Classical Swine Fever Vaccines Sales Forecast by Volume (2020-2035) & (K MT)
Figure 107. Global Classical Swine Fever Vaccines Market Size Forecast by Value (2020-2035) & (M USD)
Figure 108. Global Classical Swine Fever Vaccines Sales Market Share Forecast by Type (2026-2035)
Figure 109. Global Classical Swine Fever Vaccines Market Share Forecast by Type (2026-2035)
Figure 110. Global Classical Swine Fever Vaccines Sales Forecast by Application (2026-2035)
Figure 111. Global Classical Swine Fever Vaccines Market Share Forecast by Application (2026-2035)